IMRX Stock Analysis: Buy, Sell, or Hold?

IMRX - Immuneering Corporation Class A Common Stock

PHARMACEUTICAL PREPARATIONS
$4.54
0.10 (2.25%) ▲
5d: +8.35%
30d: -13.03%
90d: -11.33%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 12, 2026

Get Alerted When IMRX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: IMRX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: IMRX is currently trading at $4.54, which is considered fair relative to its 30-day fair value range of $4.14 to $5.17.

Technical Outlook: Technically, IMRX is in a strong uptrend. Immediate support is located at $3.86, while resistance sits at $4.69.

Market Sentiment: IMRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.00 (+274.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $4.14 - $5.17
Company Quality Score 56/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 86.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 274.4% below Wall St target ($17.00)

Trading Range Analysis

30-Day Trading Range $4.14 - $5.17
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $3.86
Resistance Level $4.69
Current Trend Strong Uptrend
Technical data as of Jun 23, 2026

Fundamental Context

Forward P/E (Next Year Est.) -3.39
Wall Street Target $17.00 (+274.4%)
Revenue Growth (YoY) -99.8%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 24, 2026 4:07 AM ET
Data refreshes hourly during market hours. Next update: 5:07 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Harold Eugene Brakewood BUY 5250 shares 2026-01-16
Brett Matthew Hall BUY 2298 shares 2026-01-15
Thomas J Schall BUY 21645 shares 2026-01-15

Unlock Insider Activity

See real-time buying/selling by company executives for IMRX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
19 analysts
$81 67 BUY
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$34 61 BUY
MNMD
Mind Medicine Inc
STRONG BUY
11 analysts
$29 62 BUY
ALLO
Allogene Therapeutics Inc
STRONG BUY
14 analysts
$8 60 HOLD
IRON
Disc Medicine Inc.
STRONG BUY
11 analysts
$102 59 HOLD

More Analysis for IMRX

IMRX Technical Chart IMRX Price Prediction IMRX Earnings Date IMRX Investment Advisor IMRX Fair Price Analyzer IMRX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals